Oil Prices Rebound as U.S.-Iran Talk Uncertainty Keeps Markets on Edge 
US Stock Futures Rise as Trump Signals Iran Talks, Markets Await SpaceX Earnings and Jobs Data 
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review 
Gold Ends July Higher as Weaker Dollar Offsets Fed Inflation Concerns 
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits 
Dollar Posts Worst Monthly Loss Since April as Fed Uncertainty and Yen Intervention Shake FX Markets 
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat 
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat 
UK Economy Faces 2027 Recession Risk if Strait of Hormuz Stays Closed, EY Warns 
India Plans Tax Reforms to Boost Foreign Investment and Manufacturing 
Oil Prices Drop Nearly 5% as Trump Delays Iran Strike, Markets Eye Strait of Hormuz Deal 
KOSPI Drops Nearly 5% as Samsung, SK Hynix Lead AI Stock Selloff 
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges 
Capital One Says AML Review Led to Closure of Trump Organization Accounts 
Japan Economy Minister Downplays Inflation Risks Despite BOJ Warning 
US Signals More Joint Yen Intervention With Japan if Currency Volatility Continues 
Namyang Dairy saw a surge in its shares after claiming its Bulgaris yogurt variants can help lower the risk of COVID-19 infection. The company's day trading on Wednesday, April 14, reportedly increased.
As per The Korea Herald, Namyang Dairy’s shares once shot up by 28.68% to KRW489,000 or around $437.39 in the early morning trading. It was added that within 20 minutes after the opening bell, the company’s preferred stocks also surge by the daily allowable limit of 29.78% to reach KRW231,000.
Prior to Wednesday’s results, it was reported that the firm’s shares went up 7.19% and 6.71% on Friday and Monday, respectively. It then increased again by 8.57% on Tuesday, and this shows that Namyang Dairy’s shares have been on the rise since last weekend and continued this week.
Namyang’s COVID-19 claim
Observers are saying that the company’s surge in shares may be due to its claims that its Bulgaris yogurt lineup can help reduce the risk of getting COVID-19. Some market insiders also think that some investors may have also used information that caused the hike in the recent stock tradings.
At any rate, what triggered the sudden increase in shares of Namyang Dairy was the statement given by the company during a news conference in Seoul.
“We’re the first firm in the country that has discovered fermented dairy products are effective in preventing influenza and COVID-19 viruses,” Namyang’s chief of antiviral immune research center, Park Jong Su, said at that time. “Our experiments showed that Bulgaris helped remove the Influenza A (H1N1) virus at a 99.999 percent rate of success, and the COVID-19 at a 77.8 percent success rate.”
He added that the test of the yogurt’s effectiveness in fighting coronavirus was done using the lung cells of a monkey. As a result of this claim, people reportedly rushed out to purchase Namyang Dairy’s Bulgaris yogurts in stores.
Statement from S. Korea’s health officials
After the announcement from Namyang, the public health authorities released a statement. The agency expressed its concern over the claims.
“The latest research result has not proved to be effective in eliminating those viruses in the human body,” the Korea Disease Control and Prevention Agency stated. “Therefore, it is hard to say whether it can serve as an actual prevention or treatment measure for (the viruses).”
